COMPLETED

Addressing Cancer-Related Financial Toxicity in Rural Oncology Care Settings

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The financial burden, or financial toxicity (FT), of cancer is a consequential and growing problem, particularly for rural patients. It is important to improve our understanding of how financial navigation (FN) can reduce the material, psychological, and behavioral burden of costs associated with cancer care in both rural and non-rural community settings. The purpose of this study is to conduct a financial navigation program in 5 rural and 4 non-rural oncology practices in North Carolina and evaluate the effects of financial navigation on patient outcomes, including financial toxicity and health-related quality of life.

Official Title

Addressing Cancer-Related Financial Toxicity in Rural North Carolina Oncology Care Settings

Quick Facts

Study Start:2021-11-11
Study Completion:2025-07-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT04931251

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients 18 years of age and older
  2. * Patients with any type of cancer diagnosed within 5 years and/or living with advanced disease
  3. * Patients who score 22 or lower on the COST measure indicating high FT
  4. * Patients must be able to read and speak English
  1. * Participants without a cancer diagnosis
  2. * Patients diagnosed more than 5 years ago without advanced disease
  3. * Patients or caregivers under the age of 18
  4. * Patients who do not sign the consent form
  5. * Patients who do not complete the baseline COST survey
  6. * Patients who cannot read and speak English

Contacts and Locations

Principal Investigator

Stephanie Wheeler, PhD
PRINCIPAL_INVESTIGATOR
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill

Study Locations (Sites)

NC Basnight Cancer Hospital
Chapel Hill, North Carolina, 27514
United States
Novant Health
Charlotte, North Carolina, 28207
United States
Vidant Medical Center, Cancer Center
Greenville, North Carolina, 27834
United States
Pardee UNC Health Care, Pardee Cancer Center
Hendersonville, North Carolina, 28739
United States
UNC Lenoir Cancer Care Services
Kinston, North Carolina, 28501
United States
Carteret Health Care Cancer Center
Morehead City, North Carolina, 28557
United States
The Outer Banks Hospital
Nags Head, North Carolina, 27959
United States
Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157
United States

Collaborators and Investigators

Sponsor: UNC Lineberger Comprehensive Cancer Center

  • Stephanie Wheeler, PhD, PRINCIPAL_INVESTIGATOR, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-11-11
Study Completion Date2025-07-31

Study Record Updates

Study Start Date2021-11-11
Study Completion Date2025-07-31

Terms related to this study

Keywords Provided by Researchers

  • Financial Toxicity
  • Cancer
  • Financial Navigation
  • Carcinoma
  • Neoplasms

Additional Relevant MeSH Terms

  • Neoplasms
  • Carcinoma